William Blair analyst Brandon Vazquez has maintained their bullish stance on ALGN stock, giving a Buy rating on August 27.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Brandon Vazquez has given his Buy rating due to a combination of factors that highlight Align Tech’s strategic initiatives and market positioning. The company’s focus on digitized care and improving patient conversion rates is a key driver for future growth. Additionally, Align Tech is working on expanding its pricing options to better align with orthodontic spending habits, which is expected to enhance its competitive edge by the end of the year.
Moreover, the company is implementing more targeted marketing campaigns to attract a broader patient base and is optimizing its supply chain through localized manufacturing to reduce freight costs. With shares trading at 13 times the estimated earnings per share for 2026, Vazquez sees a favorable risk/reward profile, justifying the Buy rating.
In another report released on August 27, Leerink Partners also reiterated a Buy rating on the stock with a $188.00 price target.
Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ALGN in relation to earlier this year.